Effect of hypoxia-inducible factor 1-α on Survivin in colorectal cancer

Molecular Medicine Reports

Volumn 3, Issue 3, 2010, Pages 409-415

  Wu, Xing Ye ^a   Fu, Zhong Xue ^a   Wang, Xue Hu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Hypoxia inducible factor 1 ; Survivin

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; RNA; SODIUM CHLORIDE; SURVIVIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CANCER THERAPY; CANCER TISSUE; CELL HYPOXIA; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT;

EID: 77952412589     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000273     Document Type: Article

References (21)

1. Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT and Griffiths S: obstacles to colorectal cancer screening in chinese: a study based on the health belief model. Am J Gastroenterol 103: 974-981, 2008.
2. Wu XZ: New strategy of antiangiogenic therapy for hepatocellular carcinoma. Neoplasma 55: 472-481, 2008.
3. Hockel M, Schlenger K, aral B, Mitze M, Schaffer u and vaupel P: association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. cancer Res 56: 4509-4515, 1996.
4. deveraux QL and reed JC: iaP family proteins - suppressors of apoptosis. Genes dev 13: 239-252, 1999.
5. ambrosini G, adida c and altieri DC: a novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. nat Med 3: 917-921, 1997.
6. Peng XH, Karna P, cao Z, Jiang BH, Zhou M and Yang l: cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol chem 281: 25903-25914, 2006.
7. chang Q, Qin r, Huang T, Gao J and Feng Y: effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 32: 297-305, 2006.
8. Martinive P, defresne F, Bouzin c, et al: Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. cancer res 66: 11736-11744, 2006.
9. Shen W, Wang cY, Wang XH and Fu ZX: oncolytic adenovirus mediated Survivin knockdown by rna interference suppresses human colorectal carcinoma growth in vitro and in vivo. J exp clin cancer res 28: 81, 2009.
10. Filleur S, courtin a, ait-Si-Ali S, et al: Sirna-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. cancer res 63: 3919-3922, 2003.
11. Toffoli S and Michiels c: intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 275: 2991-3002, 2008.
12. Melillo G: inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol cancer res 4: 601-605, 2006. (Pubitemid 44497213)
13. Powis G and Kirkpatrick l: Hypoxia inducible factor-1 alpha as a cancer drug target. Mol cancer Ther 3: 647-654, 2004.
14. Haberler c, Slavc i, czech T, et al: Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome. eur J cancer 42: 2996-3003, 2006.
15. Sohn DM, Kim SY, Baek MJ, lim CW, lee MH, cho MS and Kim TY: expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacother 60: 289-292, 2006.
16. Akyürek N, Memiş L, Ekinci O, Köktürk N and Oztürk C: Survivin expression in pre-invasive lesions and non-small cell lung carcinoma. virchows arch 449: 164-170, 2006.
17. Rödel F, Hoffmann J, Distel L, et al: Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. cancer res 65: 4881-4887, 2005.
18. chen YQ, Zhao CL and Li W: effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer. J exp clin cancer res 28: 29, 2009.
19. Yang l, cao Z, li F, Post DE, van Meir EG, Zhong H and Wood C: Tumor-specific gene expression using the Survivin promoter is further increased by hypoxia. Gene Ther 11: 1215-1223, 2004.
20. Semenza GL: Targeting HIF-1 for cancer therapy. nat rev cancer 3: 721-732, 2003.
21. Manalo DJ, Rowan A, lavoie T, et al: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669, 2005.